14q32 chromosomal translocations: A hallmark of plasma cell dyscrasias?

Hematology Journal

Volumn 1, Issue 5, 2000, Pages 292-294

  Avet Loiseau, Hervé ^a,b   Minvielle, Stéphane ^a   Mellerin, Marie Paule ^a   Magrangeas, Florence ^a   Bataille, Régis ^a  

^a INSERM   (France)

^b INSTITUT DE BIOLOGIE   (France)

Author keywords

Cytogenetics; Fluorescence in situ hybridization; IGH gene; Myeloma

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN; PARAPROTEIN;

ARTICLE; CHROMOSOME 14; GENE REARRANGEMENT; GENE TRANSLOCATION; GENETICS; HUMAN; IMMUNOGLOBULIN GENE; MULTIPLE MYELOMA; PARAPROTEINEMIA; PATHOLOGY; ULTRASTRUCTURE;

CHROMOSOMES, HUMAN, PAIR 14; GENE REARRANGEMENT, B-LYMPHOCYTE, HEAVY CHAIN; GENES, IMMUNOGLOBULIN; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; MULTIPLE MYELOMA; MYELOMA PROTEINS; PARAPROTEINEMIAS; TRANSLOCATION, GENETIC;

EID: 0034585919     PISSN: 14664860     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.thj.6200045     Document Type: Article

References (20)

1. Bataille R, Harousseau JL. Multiple myeloma. New England Journal of Medicine 336: 1657, 1997.
2. Laï JL, Zandecki M, Mary JY, Bernardi F, Izydorczyk V, Flactif M, Morel P, Jouet JP, Bauters F, Facon T. Improved cytogenetics in multiple myeloma: A study of 151 patients including 117 patients at diagnosis. Blood 85: 2490, 1995.
3. Sawyer JR, Waldron JA, Jagannath S, Barlogie B. Cytogenetics findings in 200 patients with multiple myeloma. Cancer Genetics & Cytogenetics 82: 41, 1995.
4. Nishida K, Tamura A, Nakazawa N, Ueda Y, Abe T, Matsuda F, Kashima K, Taniwaki M. The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization. Blood 90: 526, 1997.
5. Avet-Loiseau H, Li JY, Facon T, Brigaudeau C, Morineau N, Maloisel F, Rapp MJ, Talmant P, Trimoreau F, Jaccard A, Harousseau JL, Bataille R. High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignancies. Cancer Research 58: 5640, 1998.
6. Bergsagel PL, Chesi M, Nardini E, Brents LA, Kirby SL, Kuehl WM. Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma. Proceedings of the National Academy of Sciences, USA 93: 13931, 1996.
7. Bensimon A, Simon A, Chiffaudel A, Croquette V, Heslot F, Bensimon D. Alignment and sensitive detection of DNA by a moving interface. Science 265: 2096, 1994.
8. Kuipers J, Vaandrager JW, Weghuis DO, Pearson PL, Schers J, Lokhorst HM, Clevers H, Bast BJEG. Fluorescence in situ hybridization analysis shows the frequent occurrence of 14q32.3 rearrangements with involvement of immunoglobulin switch regions in myeloma cell lines. Cancer Genetics & Cytogenetics 109: 99, 1999.
9. Richelda R, Ronchetti D, Baldini L, Cro L, Viggiano L, Marzella R, Rocchi M, Otsuki T, Lombardi L, Maiolo AT, Neri A. A novel chromosomal translocation t(4;14)(p16.3;q32) in multiple myeloma involves the fibroblast growth factor receptor 3 gene. Blood 90: 4062, 1997.
10. Avet-Loiseau H, Li JY, Morineau N, Facon T, Brigaudeau C, Harousseau JL, Grosbois B, Bataille R, on behalf of the Intergroupe Francophone du Myélome. Monosomy 13 is associated with the transition of monoclonal gammopathy of undetermined significance to multiple myeloma. Blood 94: 2583, 1999.
11. Avet-Loiseau H, Facon T, Daviet A, Godon C, Rapp MJ, Harousseau JL, Grosbois B, Bataille R, on behalf of the Intergroupe Francophone du Myélome. 14q32 translocations and monosomy 13 observed in monoclonal gammopathy of undetermined significance delineate a multistep process for the oncogenesis of multiple myeloma. Cancer Research 59: 4546, 1999.
12. Avet-Loiseau H, Brigaudeau C, Talmant P, Laï JL, Daviet A, Li JY, Praloran V, Rapp MJ, Harousseau JL, Facon T, Bataille R. High incidence of cryptic translocations involving the Ig heavy chain gene in multiple myeloma, as shown by fluorescence in situ hybridization. Genes Chromosomes Cancer 24: 9, 1999.
13. Sawyer JR, Lukacs JL, Munshi N, Desikan KR, Singhal S, Mehta J, Siegel D, Shaughnessy J, Barlogie B. Identification of new nonrandom translocations in multiple myeloma with multicolor spectral karyotyping. Blood 92: 4269, 1998.
14. Eton O, Scheiberg DA, Houghton AN. Establishment and characterization of two human myeloma cell lines secreting kappa light chains. Leukemia 3: 729, 1989.
15. Chesi M, Bergsagel PL, Brents LA, Smith CM, Gerhard DS, Kuehl WM. Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines. Blood 88: 674, 1996.
16. Chesi M, Nardini E, Brents LA, Schröck E, Ried T, Kuehl WM, Bergsagel PL. Frequent translocation t(4;14)(p16.3;14q32) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor 3. Nature Genetics 16: 260, 1997.
17. Chesi M, Nardini E, Lim RSC, Smith KD, Kuehl WM, Bergsagel PL. The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybridization transcripts. Blood 92: 3025, 1998.
18. Chesi M, Bergsagel PL, Shonukan OO, Martelli ML, Brents LA, Chen T, Schröck E, Ried T, Kuehl WM. Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma. Blood 91: 4457, 1998.
19. Iida S, Rao PH, Butler M, Corradini P, Boccadoro M, Klein B, Chaganti RSK, Dalla-Favera R. Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma. Nature Genetics 17: 226, 1997.
20. Dalla-Favera R. Molecular analysis of chromosomal aberrations in multiple myeloma. VII International Multiple Myeloma Workshop, September 1999, Stockholm, I6 (Abstract).